Functional, Dynamic, and Anatomic MR Urography
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
This is a clinical feasibility study to assess the value of MR imaging for obtaining functional, dynamic and anatomical information in a comprehensive imaging protocol in subjects having obstructive uropathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2001
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2001
CompletedFirst Submitted
Initial submission to the registry
December 26, 2007
CompletedFirst Posted
Study publicly available on registry
January 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedMay 30, 2017
May 1, 2017
12.1 years
December 26, 2007
May 25, 2017
Conditions
Keywords
Study Arms (2)
1
Patients with two kidneys
2
Patients with solitary kidney
Eligibility Criteria
Patients who have been diagnosed with obstructive uropathy
You may qualify if:
- Males or females 18 years of age or older.
- All female patients of childbearing potential must agree to use a medically accepted method of contraception at the time of the study.
- Patients must have the ability to understand the requirements of the study, provide written and informed consent to participate, and agree to abide by the study requirements.
- Patients who have known or suspected hydronephrosis or patients with solitary kidneys.
You may not qualify if:
- Patients with known or suspected hypersensitivity to gadolinium-based agents.
- Patients who are pregnant or lactating.
- Patients with a condition that is a contraindication to MRI (e.g., cardiac pacemaker, epicardial pacemaker leads, cochlear implants, ferromagnetic aneurysm clip, ferromagnetic halo device, or other conditions that would preclude patient proximity to a strong external magnetic field).
- Patients with a recent history of hemolytic anemia, sickle cell anemia or other hemoglobinopathy.
- Patients with a history of significant claustrophobia.
- Patients with impaired renal function based on 24-hr urine collection (creatinine clearance \<10 ml/min or serum creatinine \>1.8 mg/dl)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Katzburg, MD
University of California, Davis
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2007
First Posted
January 3, 2008
Study Start
April 1, 2001
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
May 30, 2017
Record last verified: 2017-05